A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors.

Saved in:
Bibliographic Details
Title: A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors.
Authors: LoRusso, Patricia M.1 patricia.lorusso@yale.edu, Infante, Jeffrey R.2,3, Kim, Kevin B.4, Burris, Howard A.2,3, Curt, Gregory5, Ugochi Emeribe5, Clemett, Delyth6, Tomkinson, Helen K.6, Cohen, Roger B.7, Burris, Howard A 3rd2,3 (AUTHOR), Emeribe, Ugochi5 (AUTHOR)
Source: BMC Cancer. 3/6/2017, Vol. 17, p1-13. 13p. 1 Diagram, 4 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:14712407
DOI:10.1186/s12885-017-3143-6